Author response: "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy"

J Crit Care. 2022 Aug:70:154059. doi: 10.1016/j.jcrc.2022.154059. Epub 2022 May 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefepime
  • Ceftazidime*
  • Continuous Renal Replacement Therapy*
  • Critical Illness
  • Humans
  • Renal Replacement Therapy

Substances

  • Anti-Bacterial Agents
  • Cefepime
  • Ceftazidime